ADB 102
Alternative Names: ADB-102Latest Information Update: 18 Aug 2023
At a glance
- Originator Adolore Biotherapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Pain